20140210

February 2014 P&T Journal Digital Edition



Dear VIJAY PITHADIA:
Your February 2014 digital issue of P&T journal is available.

This issue contains:

Feature articles
 
  • PHARMACOVIGILANCE FORUM
    Specialty Pharmacy Networks for Hospitals in the Offing
    Absence of Onsite Access to Specialty Pharmaceuticals Has Care and Financial Implications
    Two competing hospital networks are assembling specialty pharmacy programs to satisfy drug manufacturers' requirements for delivery of costly, restricted distribution drugs to hospitals. Hospitals' inability to dispense such drugs can affect patient care and revenue.
     
  • HEALTH CARE & LAW
    Implications of Recent Controlled Substance Policy Initiatives
    Legislative and regulatory efforts to address controlled substance diversion and overuse of narcotics are affecting prescription drug utilization and patient care. These initiatives can influence formulary drug selection, prior authorization procedures, and drug utilization strategies.
     
  • Drugs That Offer a Survival Advantage For Men With Bone Metastases Resulting From Castration-Resistant Prostate Cancer
    New and Emerging Treatment Options
    A survival benefit has been demonstrated or is under investigation as the primary outcome among certain recently approved agents and investigational agents for men with metastatic castration-resistant prostate cancer that has spread to bone.
     
  • MEETING HIGHLIGHTS
    American Society of Hematology
    55th Annual Meeting and Exposition
    Topics include pharmacological treatments for sickle-cell disease, myelofibrosis, multiple myeloma, chronic myeloid leukemia, and ß-Thalassemia.
     
Plus our regular columns: Medication Errors, Prescription: Washington, New Drugs/Drug News/New Medical Devices, Pharmaceutical Approval Update, and Drug Forecast.
Click here to begin reading the current issue.

Click here to subscribe to P&T journal

Call for Papers
P&T is accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please contact Sonja Sherritze, via phone (267-685-2779) or mobile 267-907-5642) or e-mail (ssherritze@medimedia.com) for more information.


We hope you enjoy this issue of P&T. If you have any comments or questions about this digital format, please e-mail us atmail@ptcommunity.com.

Sonja Sherritze
Editor